Icon PLC Company Profile (NASDAQ:ICLR)

Analyst Ratings

Consensus Ratings for Icon PLC (NASDAQ:ICLR) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: $77.33 (8.60% upside)

Analysts' Ratings History for Icon PLC (NASDAQ:ICLR)
Show:
DateFirmActionRatingPrice TargetActions
6/27/2016Robert W. BairdReiterated RatingOutperform$83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016Credit Suisse Group AGInitiated CoverageOutperform$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2016Jefferies GroupReiterated RatingHold$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Avondale PartnersDowngradeMarket Perform -> Underperform$70.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016KeyCorpReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016SunTrust Banks Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Goldman Sachs Group Inc.Boost Price TargetNeutral$75.00 -> $79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Barclays PLCBoost Price TargetEqual Weight$58.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2014First AnalysisDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/10/2014Evercore ISIDowngradeBuy -> Neutral$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Icon PLC (NASDAQ:ICLR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
7/26/2016Q216$1.14$1.14$409.97 million$411.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2016Q116$1.11$1.12$414.35 million$400.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415$1.10$1.11$409.42 million$403.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$1.01$1.02$399.02 million$394.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215$0.89$0.95$402.15 million$389.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115$0.82$0.86$391.11 million$388.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q4$0.76$0.87$391.37 million$390.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q314$0.70$0.79$391.12 million$388.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q2$0.58$0.64$376.89 million$376.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q1$0.50$0.57$352.14 million$350.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2014Q413$0.45$0.53$339.86 million$345.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q313$0.41$0.45$332.58 million$339.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013$0.38$0.43$321.82 million$334.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q1 2013$0.34$0.36$300.81 million$317.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2013Q4 2012$0.33$0.34$291.96 million$300.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.27$0.29$282.67 million$286.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2012$0.22$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2012$0.15$0.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/16/2012$0.08$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$0.02$0.02ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/20/2011$0.22$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2011$0.21$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011$0.36$0.36ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Icon PLC (NASDAQ:ICLR)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$1.04$1.14$1.10
Q2 20165$1.10$1.15$1.13
Q3 20165$1.15$1.20$1.18
Q4 20165$1.21$1.32$1.26
Q1 20172$1.25$1.37$1.31
Q2 20171$1.38$1.38$1.38
Q3 20171$1.39$1.39$1.39
Q4 20171$1.47$1.47$1.47
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Icon PLC (NASDAQ:ICLR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Icon PLC (NASDAQ:ICLR)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Icon PLC (NASDAQ:ICLR)
DateHeadline
07/25/16 09:07 AMHealthcare Earnings Scheduled on Jul 26: CNC, ICLR, UHS
07/25/16 05:18 AMICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting - [at noodls] - DUBLIN--(BUSINESS WIRE)-- ICONplc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that all ...
07/22/16 04:31 PMRanger Investment Management LP Increased Icon Plc Ads (NASDAQ:ICLR) by $7.30 Million as Shares Rose - Press Telegraph
07/22/16 07:32 AMBroker Outlook For ICON Plc (NASDAQ:ICLR) - Fiscal Standard
07/21/16 07:53 AMICON plc (NASDAQ:ICLR): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 07:53 AMIcon Plc Ord (NASDAQ:ICLR) Shorted Shares Increased By 4.48% - Consumer Eagle
07/20/16 07:34 AMStephens Investment Management Group LLC Increased Icon Plc (NASDAQ:ICLR) by $5.30 Million as Shares Rose - Consumer Eagle
07/20/16 07:34 AMHow Many ICON PLC (NASDAQ:ICLR)'s Analysts Are Bullish? - Consumer Eagle
07/20/16 07:34 AMAcadian Asset Management LLC Sells A Little More ICON plc (ICLR) Stock - Finance Daily
07/19/16 11:34 AMETF’s with exposure to ICON Plc : July 19, 2016 -
07/17/16 08:58 AMEarnest Partners LLC Decreased Stake in Icon Plc (NASDAQ:ICLR) by $16.97 Million as Shares Rose - Consumer Eagle
07/12/16 04:50 PMApex Capital Management Increased Icon Plc (NASDAQ:ICLR) by $5.19 Million as Shares Rose - Consumer Eagle
07/09/16 04:11 PMLarge Inflow of Money Witnessed in ICON plc - TheFounders Daily
07/07/16 07:27 AMICON plc (ICLR) : Analyst Rating Update - Trade Calls
07/06/16 04:48 PMCan ICON plc (NASDAQ:ICLR) Improve on the Earnings Front? - Engelwood Daily
07/06/16 09:14 AMIcon Plc Ord (NASDAQ:ICLR) Sellers Increased By 26.39% Their Shorts - Engelwood Daily
07/06/16 09:14 AMICON Plc (NASDAQ:ICLR) Broker Price Targets For The Coming Week - Fiscal Standard
07/01/16 05:19 PMETF’s with exposure to ICON Plc : July 1, 2016 -
07/01/16 04:35 PMICON Plc (NASDAQ:ICLR) Current Analyst Ratings - Fiscal Standard
06/30/16 04:49 PMICON buys CRO Clinical Research Management
06/30/16 04:49 PMICON plc (ICLR) to Acquire ClinicalRM
06/30/16 07:27 AMICON plc (ICLR) to Acquire ClinicalRM - StreetInsider.com
06/28/16 11:47 AMICON Plc :ICLR-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 -
06/28/16 09:27 AMCovering the Bases on ICON plc (NASDAQ:ICLR): Where is the Stock Going? - Press Telegraph
06/28/16 09:27 AMCredit Suisse Initiates Coverage on ICON PLC to Outperform - Trade Calls
06/28/16 09:19 AMHealthcare Opportunities in Light of Brexit-Driven Sell-Off -
06/27/16 07:06 AMICON Plc breached its 50 day moving average in a Bullish Manner : ICLR-US : June 27, 2016 -
06/25/16 08:23 AMICON May Miss Revenue Guidance, But Baird Still Bullish
06/24/16 07:11 AMRanger Investment Management LP Increased Icon Plc Ads (NASDAQ:ICLR) by $7.30 Million as Shares Rose - Engelwood Daily
06/23/16 04:54 PMDIA Live to Provide a Digital Window into DIA Conference 2016
06/23/16 04:54 PMIcon PLC (NASDAQ:ICLR) target price upped to $80 as reported today by Credit Suisse
06/23/16 02:09 AMICON: DIA Live to Provide a Digital Window into DIA Conference 2016 - [at noodls] - Social media aggregation site will highlight digital conversation hotspots and help amplify thought leadership and debate at DIA 2016 DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a global provider ...
06/22/16 09:14 AMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Icon Plc (NASDAQ: ICLR) and Charles River ... - Analyst Ratings
06/20/16 04:24 PMIcon PLC (NASDAQ:ICLR) price target maintained to $0, reported today by Avondale Partners - Breaking Finance News
06/20/16 10:13 AMIcon PLC (NASDAQ:ICLR) price target maintained to $0, reported today by Avondale Partners
06/17/16 07:17 AMICON PLC (NASDAQ:ICLR), Pfizer, Inc. (NYSE:PFE) Renew Partnership Agreement - Market Exclusive
06/16/16 04:35 PMICON : New Research from ICON Demonstrates Support for ‘Bring Your Own Device’ Approach in Clinical Trials
06/15/16 04:38 PMWhat Is Mean Rating On ICON plc (NASDAQ:ICLR)? - Stocks Daily
06/15/16 09:12 AMICON : New Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical Trials
06/15/16 09:12 AMNew Research from ICON Demonstrates Support for 'Bring Your Own Device' Approach in Clinical Trials
06/15/16 08:12 AMICON and Pfizer Extend Ties, Sign New Agreement -
06/15/16 02:09 AMNew Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical Trials - [at noodls] - Research shows that commonly-cited equivalence and technical concerns around BYOD may not deter adoption DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions ...
06/15/16 02:00 AMNew Research from ICON Demonstrates Support for ‘Bring Your Own Device’ Approach in Clinical Trials - [Business Wire] - ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced research showing many pharmaceutical and clinical research organisations support the use of a ‘Bring Your Own Device’ approach in clinical studies, enabling patients to use their own mobile devices to collect patient-reported outcomes data.
06/10/16 07:18 AMICON plc (ICLR) Enters New Services Agreement with Pfizer (PFE) - StreetInsider.com
06/09/16 07:15 AMAvondale Worried About ICON PLC's Revenue Concentration
06/06/16 04:28 PMIs ICON PLC (NASDAQ:ICLR) Still Struggling to Survive? - Street Report
06/06/16 08:07 AMBrokers Set Expectations for Icon Plc's FY2016 Earnings (ICLR) - Let Me Know About This
06/04/16 04:35 PMWill ICON plc (NASDAQ:ICLR) Surprise Analysts? - Investor Newswire
06/04/16 04:35 PMWhy ICON PLC (NASDAQ:ICLR) Got Downgraded? - The Point Review
06/03/16 04:54 PMJefferies Group Downgrades Icon Plc (ICLR) to Hold - Let Me Know About This

Social

About Icon PLC

Icon PLC logoICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ICLR
  • CUSIP:
Key Metrics:
  • Previous Close: $71.21
  • 50 Day Moving Average: $69.05
  • 200 Day Moving Average: $69.55
  • P/E Ratio: 17.00
  • P/E Growth: 0.95
  • Market Cap: $3.92B
  • Beta: 0.93
  • Current Year EPS Consensus Estimate: $4.71 EPS
  • Next Year EPS Consensus Estimate: $5.27 EPS
Additional Links:
Icon PLC (NASDAQ:ICLR) Chart for Tuesday, July, 26, 2016